Body Handbook Catalogue Profile Ranking
Screening BODY HANDBOOK
Screening ยท ยง114
Race-Free eGFR and Cystatin C
Your eGFR is the kidney number that sets drug doses and transplant priority. It's an estimate, and until 2021 the standard formula added a "Black race" multiplier that made a Black patient's kidneys look about 16% healthier than they were Delgado 2022. The new formula, CKD-EPI 2021, drops race. A second marker, cystatin C, catches the disease creatinine misses in anyone thin, frail, cirrhotic, or very muscular. Near a real decision, it's one of the highest-leverage blood tests in medicine.
Screen ยท As-needed Evidence Strong Chapter Screening

eGFR is estimated from creatinine, which your muscles make, so a marathoner and a frail person with the same kidneys get very different numbers 1. The 2009 formula patched this by multiplying the result by 1.159 for Black patients, on an unvalidated theory about muscle mass 2. Cystatin C is the cleaner marker: every cell makes it at a near-constant rate, so it barely cares whether you're frail or jacked. Run with creatinine, the combined formula lands within 30% of true function 92% of the time, versus 87% for creatinine alone 3.

The race-free formula would newly identify about 434,000 Black adults with previously missed kidney disease 4. On the transplant list, 27% of Black candidates moved into a higher-priority stage, worth roughly 5.3 more transplants per 1,000 5. Cystatin C reaches everyone: when the two markers disagree and cystatin C reads much lower, that gap alone predicts a death rate about 70% higher, a hazard on the order of being a current smoker 6.

Who this is for. Anyone whose muscle is unusual for their age โ€” the frail and cirrhotic, or the bodybuilders and creatine users. Anyone Black whose recent creatinine eGFR came back between 50 and 70. Anyone facing a decision the number drives. Healthy, with an eGFR above 60? Skip it.

What the number buys. Within a week your charted kidney figure is the most accurate you've had, and for most people nothing changes. For the person carrying hidden disease, the next visit adds a nephrology referral and, if diabetes is in play, an SGLT2 inhibitor; caught before symptoms, the first ninety days are where the trajectory bends. For the person about to take a kidney-stressing drug, the dose is set from a true number, and the acute injury never happens 7.

The fine print โ€” when to skip it, and what people get wrong

When cystatin C also misleads: active infection, an autoimmune flare, recent surgery, oral or IV steroids, and untreated hyperthyroidism all raise it without harming the kidneys 8. Wait until you're back at baseline, or trust the creatinine instead.

"Dropping race hurts Black patients." The reverse โ€” it reveals hidden disease and shortens transplant waits 5. Living-donor evaluation is the one exception it wasn't built for.

"Cystatin C replaces creatinine." No โ€” the combined formula beats either alone, which is why KDIGO recommends both 9.

References
  1. 1Shlipak MG, Inker LA, Coresh J (2022). Serum Cystatin C for Estimation of GFR. JAMA. link
  2. 2Delgado C, Baweja M, Crews DC, et al. (2022). A Unifying Approach for GFR Estimation: Recommendations of the NKF-ASN Task Force on Reassessing the Inclusion of Race in Diagnosing Kidney Disease. American Journal of Kidney Diseases. link
  3. 3Inker LA, Eneanya ND, Coresh J, et al. (2021). New Creatinine- and Cystatin C-Based Equations to Estimate GFR without Race. New England Journal of Medicine. link
  4. 4Diao JA, Wu GJ, Taylor HA, et al. (2021). Clinical Implications of Removing Race From Estimates of Kidney Function. JAMA. link
  5. 5Mohottige D, Boulware LE, Diao JA, et al. (2024). Removing race from kidney function algorithm impact on Black candidates for kidney transplantation. JAMA Internal Medicine. link
  6. 6Estrella MM, Carrero JJ, Inker LA, et al. (2025). Discordance in Creatinine- and Cystatin C-Based eGFR and Clinical Outcomes: A Meta-Analysis. JAMA. link
  7. 7Davis JD, Olsen MA, Bommelaere C, et al. (2020). Use of Intravenous Iodinated Contrast Media in Patients with Kidney Disease: Consensus Statements from the American College of Radiology and the National Kidney Foundation. Radiology. link
  8. 8Chen TK, Knicely DH, Grams ME (2022). Advantages, Limitations, and Clinical Considerations in Using Cystatin C to Estimate GFR. Kidney360. link
  9. 9KDIGO (2024). KDIGO 2024 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease. Kidney International. link
Related in the handbook (9)
Diagnosis
  • โ€” This is the number that stages early kidney disease โ€” get it right and you catch CKD in the window that matters.
Related
  • โ€” Your eGFR feeds straight into the PREVENT heart-risk score; a race-free, cystatin-C reading keeps that estimate honest.
  • โ€” Creatine supplements inflate the creatinine your eGFR is built on; cystatin C reads through the artefact.
  • โ€” Just as diabetes is screened in the eye each year, the kidney gets watched with eGFR and cystatin C.
  • โ€” Same lesson, different lab: a single standard number can mislead in specific people. Know when your eGFR, like your HbA1c, needs a second marker.
  • โ€” A reassuring eGFR can hide real disease โ€” exactly the 'normal isn't the same as fine' problem.
  • โ€” Another everyday medical tool that was quietly less accurate for some patients โ€” same lesson about not trusting a single number blindly.
  • โ€” Same skill on a different organ: knowing what your kidney numbers actually mean and their limits.
  • โ€” Your eGFR is the number that decides if this swap is safe or dangerous โ€” bad kidneys can't clear the extra potassium.
ยท
114